8 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18917836 | EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | Oct 16, 2024 |
| 18501627 | COMPOSITION AND METHODS FOR INDUCING MYELOID SUPPRESSIVE CELLS AND USE THEREOF | O'NEILL, MARISOL ANN | 1633 | Non-Final OA | Nov 03, 2023 |
| 18028457 | ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS | GODDARD, LAURA B | 1642 | Non-Final OA | Mar 24, 2023 |
| 17782600 | ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS | WESTON, ALYSSA G | 1633 | Final Rejection | Jun 03, 2022 |
| 17769651 | ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF | ZHU, JIANJIAN | 1631 | Non-Final OA | Apr 15, 2022 |
| 17762693 | MULTI-TARGETING EFFECTOR CELLS AND USE THEREOF | MATALKAH, FATIMAH KHALAF | 1638 | Final Rejection | Mar 22, 2022 |
| 17438317 | CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS | GONZALES, JOSEPHINE MARIA | 1631 | Final Rejection | Sep 10, 2021 |
| 17040951 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | DHAR, MATASHA | 1632 | Non-Final OA | Sep 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial